This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
New Strong Sell Stocks for June 27th
by Zacks Equity Research
FFNW, LGGNY and NDSN have been added to the Zacks Rank #5 (Strong Sell) List on June 27, 2024.
Best Momentum Stocks to Buy for March 27th
by Zacks Equity Research
KFY, SHECY and LGGNY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 27, 2023.
Best Income Stocks to Buy for March 22nd
by Santanu Roy
GOOD, LGGNY and REYN made it to the Zacks Rank #1 (Strong Buy) income stocks list on March 22, 2024.
Best Income Stocks to Buy for March 20th
by Zacks Equity Research
SBSI, LGGNY and GNTY made it to the Zacks Rank #1 (Strong Buy) income stocks list on March 20, 2024.
Should Value Investors Buy Ageas (AGESY) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Allianz (ALIZY) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Legal & General Group (LGGNY) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Legal & General Group (LGGNY) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Axa (AXAHY) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why You Should Hold Radian Group (RDN) in Your Portfolio
by Zacks Equity Research
Radian Group (RDN) is poised to grow attributable to a strong purchase market, higher monthly premium policy insurance in force and solid capital position.
Prudential Financial (PRU) Gains From Solid Segmental Show
by Zacks Equity Research
Prudential Financial (PRU) continues to benefit from lower expenses, higher earnings from joint venture investments and a robust capital position.
Recent Price Trend in Legal & General Group PLC (LGGNY) is Your Friend, Here's Why
by Zacks Equity Research
Legal & General Group PLC (LGGNY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
MGIC Investment (MTG) Soars: Stock Adds 9.1% in Session
by Zacks Equity Research
MGIC Investment (MTG) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
5 Ultra-Cheap Value Stocks With Solid Dividends
by Zacks Equity Research
Undervalued stocks offering high-dividend yield usually make lucrative picks.
Zacks Industry Outlook Highlights: SPDR S&P Insurance ETF, Health Insurance Innovations, Erie Indemnity, Legal & General Group and Argo Group International Holdings
by Zacks Equity Research
Zacks Industry Outlook Highlights: SPDR S&P Insurance ETF, Health Insurance Innovations, Erie Indemnity, Legal & General Group and Argo Group International Holdings
U.S. Insurance Stock Outlook - April 2017
by Kalyan Nandy
The gradual improvement in the interest rate environment after almost a decade has surprisingly failed to attract investors' attention to insurance stocks.